Arterial Occlusive DiseaseAlthough atherosclerosis is the
dominant cause of arterial occlusive disease, other etiologies such
as congenital and anatomical anomalies, arterial dissection, and
remote thromboembolism can also result in arterial obstruction.
Symptoms of occlusive vascular disease primarily are end-organ
dysfunction and, in the muscle beds, pain with exercise and tissue
necrosis.AtherosclerosisAtherosclerosis can be seen in any artery,
with plaques most commonly developing in areas of low shear stress,
such as at arterial branch points. Lesions are usually
symmetrically distributed, although the rate of progression may
vary. Early lesions are confined to the intima. In advanced
lesions, both intima and media are involved, but the adventitia is
spared. Preservation of the adventitia is essential for the
vessel's structural integrity and is the basis for all
cardiovascular interventions.The hemodynamic circuit consists of
the diseased major artery, a parallel system of collateral vessels,
and the peripheral runoff bed. Collateral vessels are smaller, more
circuitous, and always have a higher resistance than the original
unobstructed artery. The stimuli for collateral development include
abnormal pressure gradients across the collateral system and
increased flow velocity through intramuscular channels that connect
to reentry vessels. Adequate collateral vessels take time to
develop but often maintain tissue viability in patients with
chronic major arterial occlusions.Generally, arterial insufficiency
occurs in medium-sized and large arteries with a 50% reduction in
arterial diameter. This correlates with a 75% narrowing of
cross-sectional area and enough resistance to decrease downstream
flow and pressure. Compensatory dilation of the vessel wall may
preserve lumen diameter as the atherosclerotic lesion develops, but
with continued growth, lesions overcome this adaptation and result
in flow limiting stenoses.Atherosclerosis develops over decades.
Significant luminal narrowing with reduced flow may produce
ischemia with increased demand (exercise), or the presenting event
may be sudden thrombosis. If there is adequate collateral flow,
single stenoses or even occlusions are reasonably well tolerated.
Severe ischemia is usually associated with multiple levels of
disease.Libby P: Atherosclerosis: the new view. Sci American
2002;286:46. [PMID: 11951331]
Dav G, Patrono C: Platelet activation and atherothrombosis. N
Engl J Med 2008;358:1638. [PMID: 19476184]
Chronic Lower Extremity Occlusive Disease
Operative TreatmentInterventional procedures, open or
endovascular, are performed both for limb salvage and for
incapacitating claudication. The choice of operative procedure
depends on the location and distribution of arterial lesions and
the patient's comorbidities. Recognition of coexistent
cardiopulmonary disease is particularly relevant, because many
patients with peripheral vascular disease also have ischemic heart
disease and/or chronic lung disease associated with tobacco use.
Preoperative cardiac functional assessment is sometimes necessary,
but preoperative myocardial revascularization is not beneficial in
patients with reasonable cardiac reserve. All patients undergoing
vascular surgery should have preoperative risk assessment.
Randomized trials have shown that perioperative beta-blocker,
angiotensin-converting enzyme (ACE) inhibitor, and statins may
reduce cardiac morbidity in patients undergoing vascular surgery.
Evidence is also emerging demonstrating the importance of
maintaining statin therapy throughout the perioperative
period.Endovascular TherapyEndovascular therapy consists of
image-guided techniques to treat diseased arterial segments from
within the lumen of the vessel. Access to the arterial system is
established by the insertion of valved sheaths, usually
percutaneously, into the access vessel, often the common femoral
artery. Steerable wires and catheters are then passed through the
vasculature under fluoroscopic guidance to the target lesion
(Figure 343). Once the target lesion is accessed, therapeutic
maneuvers, such as angioplasty, or devices, such as stents, can be
delivered. In many arterial beds, endovascular therapy is more
commonly utilized than open surgical therapy because of its
minimally invasive nature and reduction of short-term morbidity and
mortality. However, many questions remain concerning the long-term
durability of endovascular repairs, and open surgery still plays a
major role in the treatment of patients with arterial
disease.Figure 343.
Endovascular gear. A: Sheath. Inserted using Seldinger technique
into access vessel. Wires, catheters, and devices pass through the
sheath. Sheaths provide stable working access points and protect
artery. B: Catheter. Variable length, stiffness, coating, and shape
(examples: B.1, cobra; B.2, pigtail; B.3, mesenteric selective).
Catheters help steer wires through vasculature and also maintain
access in vessel. C: Guidewire. Variable diameter, length,
stiffness, and shape. Used to gain access into vasculature, cross
lesions, and deliver devices. D: Balloon catheter. E: Peripheral
stent graft. F: Peripheral nitinol self-expanding stent. G:
Aortoiliac stainless steel/Dacron stent-graft.
Percutaneous transluminal angioplasty, with or without placement
of an intravascular stent, is often the treatment of choice when
stenoses or even occlusions are relatively short and localized. As
the angioplasty balloon expands, it stretches the adventitia,
fracturing and compressing plaque, expanding the artery to widen
the lumen. Energy losses associated with a stenosis are inversely
proportionate to the fourth power of the radius; therefore, even
small increases in radius can result in substantial increases in
blood flow, although durability of the procedure is improved with
the reestablishment of a normal lumen. Concomitant stenting is
frequently performed to improve luminal expansion and the
arteriographic appearance of the lesion. Stent grafts (stents with
fabric covering) may also be used in selected cases or to repair
the inadvertent rupture of an artery during angioplasty (Figure
344).
Figure 344.
Aortoiliac occlusive disease. A: Aorta. B: Severely
stenotic/occluded iliac arteries. B.1: Widely patent iliac arteries
following balloon angioplasty and stenting (C).
Both stents and stent grafts are commonly used from the aortic
bifurcation to the distal popliteal artery. Stenting is rarely
performed below the knee, but angioplasty of tibial disease is now
common with the use of small catheters and wires. Percutaneous
mechanical and laser atherectomy are other options in removing
obstructing lesions in lower extremity atherosclerotic occlusive
disease. Mechanical atherectomy removes plaque by shaving with a
cutting or rotating catheter.For short, stenotic segments in
larger, more proximal vessels, the results of endovascular
therapies are good with 1-year success rates of 85% in common iliac
disease and 70% in external iliac disease. The results with
superficial femoral and popliteal lesions are lower (Figure 345).
The success of endovascular therapy for lower extremity occlusive
disease is inversely related to the complexity of the lesion,
defined by the number and length of stenoses treated.Figure
345.
Superficial femoral artery occlusion, angioplasty and
stent-graft. A: Common femoral artery. B: Occluded superficial
femoral artery. B.1: Recannulized, stent-grafted superficial
femoral artery. C: Profunda femoris artery. D: Stent-graft.
Since disease may recur more frequently after angioplasty than
after bypass surgery, the patient should be closely followed up
using noninvasive tests. Repeat angioplasty or stenting may be
indicated for recurrent disease, but the improvement in morbidity
and mortality of endovascular interventions may be offset by the
need for multiple repeat procedures. In general, minimally invasive
percutaneous treatment of lower extremity occlusive disease is best
used in patients of high operative risk and severe,
limb-threatening ischemia (Figure 346).Figure 346.
Comparison of outcomes for surgical and endovascular
intervention in lower extremity occlusive disease.
Surgical TreatmentAortoiliac ReconstructionOpen operations are
indicated for aortoiliac occlusive disease in younger patients with
low operative risk or patients with severe disease not amenable to
endovascular therapy. To completely bypass the aortoiliac segment,
an inverted Y-shaped prosthesis is interposed between the
infrarenal abdominal aorta and the femoral arteries, creating an
aortofemoral bypass. The goal of operation is restoration of blood
flow to the common femoral artery or, when occlusive disease of the
superficial femoral artery is present, to the profunda femoris
artery. The clinical results of aortofemoral reconstruction are
excellent, although the mortality and morbidity clearly are higher
than for endovascular therapy. The operative death rate is 5%;
early patency rate, 95%; and late patency rate (510 years
postoperatively), about 80%. Late complications may be as high as
10% and include graft-intestinal fistula formation, anastomotic
aneurysm formation, renal failure, and erectile dysfunction.Lower
risk procedures may be preferable in high-risk patients. If the
clinically important lesions are confined to one side, a
femoral-femoral or iliofemoral bypass graft can be used. A graft
from the axillary to the femoral artery (ie, axillofemoral graft)
can be used for bilateral disease. Unfortunately, these
"extra-anatomic" methods of arterial reconstruction are more prone
to late occlusion than are direct reconstructions.Femoropopliteal
ReconstructionWhen disease is confined to the femoropopliteal
segment, femoropopliteal bypass is used. The principal indication
for these operations is limb salvage. In patients with claudication
alone, the indications for femoropopliteal bypass are more
difficult to define but must include substantial disability from
claudication. For limited lesions of the superficial femoral
artery, endovascular therapy is often attempted first, with surgery
reserved for extensive disease or angioplasty failure.The best
graft for femoropopliteal bypass is an autologous greater saphenous
vein. The saphenous vein may be left in situ or removed and
reversed. In the former instance, the venous tributaries are
ligated, and special instruments are used to render the valves
incompetent. Expanded polytetrafluoroethylene (PTFE) may also be
used as a conduit, particularly for bypass to the suprageniculate
popliteal artery. Below the knee, PTFE conduits produce much lower
patency rates than saphenous veins. Operative death rates are low
(2%), and 5-year patency rates range from 60% to 80%. Limb salvage
rates are higher than graft patency rates.The profunda femoris
artery perfuses the thigh and acts as an important source of
collateral flow when the superficial femoral artery is diseased.
When there is a stenosis of the profunda, profundoplasty alone can
be performed for limb salvages with success rates of 80% when the
suprageniculate popliteal artery is patent and 4050% when the
popliteal artery is occluded. Isolated profundoplasty is rarely
helpful for treating claudication.Tibioperoneal Arterial
ReconstructionReconstruction of tibial arteries (ie, distal bypass
to the tibial, peroneal, or pedal vessels) is performed only for
limb salvage. Advancing technology allows better endovascular
therapy in the tibial vessels, with decreased short-term morbidity
and mortality, and similar gains in limb salvage when compared to
bypass surgery. However, endovascular techniques are not as widely
used in the tibial vessels, and bypass still remains the primary
mode of therapy for these patients. Autogenous saphenous veins are
preferred because prosthetic conduits have high failure rates. Due
to smaller vessel size, extensive disease, and probably the length
of the bypass conduit, these grafts are not as durable as
femoropopliteal bypass, so the limb salvage rate is substantially
higher than graft patency. The operative death rate for these
procedures is about 5%.AmputationAmputation of the limb is
necessary within 510 years in only 5% of patients presenting with
claudication. Amputation is more common if patients continue to
smoke cigarettes. Patients with multiple risk factors for
atherosclerosis and short-distance claudication are also at
increased risk for eventual limb loss. Of patients who present with
ischemic rest pain or ulceration, 510% require amputation as
initial therapy, and most eventually will require amputation if not
revascularized. Successful revascularization results in lower costs
than primary amputation and an infinite improvement in quality of
life. Occasionally, primary amputation may be preferable to
revascularization if the likelihood of successful bypass is low,
extensive foot infection is present, or the patient is
nonambulatory. Amputation levels, options, and the special needs of
amputees are covered in the section on Lower Extremity
Amputation.Hirsch AT et al: ACC/AHA 2005 guidelines for the
management of patients with peripheral arterial disease (lower
extremity, renal, mesenteric, and abdominal aortic): a
collaborative report from the American Association for Vascular
Surgery/Society for Vascular Surgery, Society for Cardiovascular
Angiography and Interventions, Society for Vascular Medicine and
Biology, Society of Interventional Radiology, and the ACC/AHA Task
Force on Practice Guidelines (Writing Committee to Develop
Guidelines for the Management of Patients with Peripheral Arterial
Disease) endorsed by the American Association of Cardiovascular and
Pulmonary Rehabilitation; National Heart, Lung, and Blood
Institute; Society for Vascular Nursing; TransAtlantic
Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll
Cardiol 2006;47:1239. [PMID: 16545667]
Norgren L et al: Inter-Society consensus for the management of
peripheral arterial disease (TASC II). TASC II Working Group. J
Vasc Surg. 2007;45(Suppl S):S5.